The Anniversary Edition
In 1999, The Beljanski Foundation was created to help cure cancer the natural way. Since then, we have been dedicated to funding research for natural, non-toxic answers to cancer by continuing the work of accomplished French molecular biologist, Dr. Mirko Beljanski. For over 40 years, Dr. Beljanski studied the environmental impact on DNA replication and transcription and found ways to prevent the duplication of unregulated cells.
Our mission is to foster and develop scientific methods for diagnosis, prevention, treatment, alleviation and cure of cancer and other chronic diseases in a natural, safe, non-toxic way.
Over the last 20 years, we have sponsored numerous ground-breaking research programs with the hope to help thousands of people beat cancer naturally. We have been working relentlessly to establish partnerships with renowned academic entities and get all the results published in peer-reviewed papers. Here is the research we have already completed, and we are working endlessly to bring more scientifically proven data and research in 2020.
- Rauwolfia vomitoria and Pao pereira reduce high PSA (prostate inflammation marker) levels in men
Rauwolfia vomitoria and Pao pereira significantly decreased PSA levels in men over a 12-month period, demonstrating the anti-inflammatory effect of extracts. This clinical study was conducted at Columbia University.
Paper: Two Herbal Extracts for Protecting Prostate Cell DNA. Burchill M. Integrative Medicine. 2010;9(2):32-36.
- Rauwolfia vomitoria extract against prostate cancer
Rauwolfia vomitoria extract significantly inhibited the growth of cancer cells and caused the cycle of prostate lymph node cancer (LNCaP) to stop. The volume of the tumor decreased by up to 70% in a study on mice. This study was conducted at Columbia University.
Paper: Anti-prostate cancer activity of β-carboline alkaloid enriched extract from Rauwolfia vomitoria. Bemis DL, Capodice JL, Gorroochurn P, Katz AE, Buttyan R. International Journal of Oncology. 2006;29:1065- 1073.
- Pao pereira extract against prostate cancer
In vivo, Pao pereira reduced tumor growth by up to 80%, inducing apoptosis of cancer cells. This study was conducted at Columbia University.
Paper: β-Carboline Alkaloid-Enriched Extract from the Amazonian Rain Forest Tree Pao Pereira Suppresses Prostate Cancer Cells. Bemis DL, Capodice JL, Desai M, Katz AE, Buttyan R. Journal of the Society for Integrative Oncology. 2009;7(2):59-65.
- Pao pereira extract against ovarian cancer
The Pao pereria plant extract increased carboplatin (chemotherapy) effects against ovarian cancer. In vivo, Pao pereira reduced tumor growth by 79% and decreased the volume of ascites by 55%. When Pao pereira was combined with carboplatin, tumor growth decreased by 97% and ascites were completely eliminated. This study was conducted at The University of Kansas Medical Center.
Paper: The plant extract of Pao pereira potentiates carboplatin effects against ovarian cancer. Yu J, Chen Q. Pharmaceutical Biology. 2014;52(1):36-43.
- Rauwolfia vomitoria extract against ovarian cancer
Rauwolfia vomitoria inhibited ovarian cancer cells, both alone and then in combination with carboplatin (chemotherapy). When combined with carboplatin, tumor size decreased by up to 90% and ascites volume decreased by up to 97%. This study was conducted at The University of Kansas Medical Center.
Paper: Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer. Yu J, Ma Y, Drisko J, Chen Q. Current Therapeutic Research. 2013;75:8-14.
- Pao pereira extract against pancreatic cancer
Studies were conducted in vitro and in vivo, confirming that Pao pereira reduced the growth of pancreatic cancer tumors by up to 72%. This study was conducted at The University of Kansas Medical Center.
Paper: Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira. Yu J, Drisko J, Chen Q. Oncology Reports. 2013;30(1):149-156.
- Rauwolfia vomitoria extract against pancreatic cancer
When pancreatic cancer cells were no longer responding to gemcitabine (chemotherapy), but treated with Rauwolfia vomitoria, the number of these cells decreased by 53%. When treated with a combination of gemcitabine and Rauwolfia vomitoria, pancreatic cancer tumors decreased by 56%. This study was conducted at The University of Kansas Medical Center.
Paper: Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Gemcitabine Effects Against Pancreatic Cancer. Yu J, Chen Q. Integrative Cancer Therapies. 2014;13(3): 217-225.
ADVANCED CANCER CELLS
- Pao pereira extract against advanced prostate cancer
Pao pereira is effective against advanced hormone resistant prostate cancer cells, and metastases. This study was conducted at Nanjing University in China.
Paper: Pao Pereira Extract Suppresses Castration-Resistant Prostate Cancer Cell Growth, Survival, and Invasion Through Inhibition of NFκB Signaling. Chang C, Zhao W, Xie B, et al. Integrative Cancer Therapies. 2014;13(3):217-225.
CANCER STEM CELLS
- Pao pereira extract against pancreatic cancer stem cells
Pao pereira reduced the pancreatic cancerous tumors formed by stem cells by up to 70%. This study was conducted at The University of Kansas Medical Center.
Paper: Extract of the Medicinal Plant Pao Pereira Inhibits Pancreatic Cancer Stem-Like Cell In Vitro and In Vivo. Dong R, Chen P, Chen Q. Integrative Cancer Therapies. 2018;17(4):1204-1215.
- Rauwolfia vomitoria extract against pancreatic cancer stem cells
Rauwolfia vomitoria reduced the formation of pancreatic cancerous tumors induced by cancer stem cells. This study was conducted at The University of Kansas Medical Center.
Paper: Inhibition of pancreatic cancer stem cells by Rauwolfia vomitoria extract. Dong R, Chen P, Chen Q. Oncology Reports. 2018;40:3144-3154.
CHEMOTHERAPY WITH RNA FRAGMENTS
- Immune support for white blood cells and platelets
Cancer patients who took Beljanski’s RNA Fragments while undergoing chemotherapy all recovered with a stronger immune system and avoided thrombocytopenia (low platelet counts). This clinical trial was conducted at Cancer Treatment Centers of America.
Paper: Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia. Levin RD, Daehler M, Grutsch JF, Hall JL, Gupta D, Lis CG. BMC Cancer. 2010;10(1):1-8.
For more information on our research and the story of The Beljanski Foundation, read
Winning The War On Cancer: The Epic Journey Towards a Natural Cure (now also available in French)
To order the English edition visit here
To order the French edition visit here
The Beljanski Foundation, Inc. is a 501(c)(3) nonprofit organization. Contributions are tax deductible in United States to the extent allowed by law. Tax ID: 13-4086570.